- Deltex Medical Group , the global leader in oesophageal Doppler monitoring, has added two new hospital accounts to its platform programme in the US. The first new hospital is a prestigious academic medical centre in the Company's Mid-Atlantic sales territory.

The hospital evaluated ODM in the third quarter of 2015 and becomes the fourth platform account in the territory since it was established in the final quarter of 2014.

The second new account is the first Veteran's Affairs hospital to decide to adopt ODM at sufficient scale to qualify as a platform programme account. Its decision to implement ODM follows a successful clinical evaluation in the second quarter of 2015 and the hospital becomes the fourth platform programme account in the Company's West Coast sales territory.

The VA provides the largest integrated health system in the USA and is entirely taxpayer funded: it operates over 150 medical centres across the US including hospitals in most major cities. The Company hopes to make further progress into VA medical centres although this is likely to be in the medium to longer term. Both new accounts have indicated that they expect to start implementation this month at around 50 probes a month and to expand usage over time.

Story provided by